Market Closed -
OTC Markets
15:52:56 20/05/2024 BST
|
5-day change
|
1st Jan Change
|
10.96
USD
|
+0.55%
|
|
-.--%
|
-25.14%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,684
|
-
|
-
|
Enterprise Value (EV)
1 |
3,570
|
3,526
|
3,520
|
P/E ratio
|
-489
x
|
154
x
|
-
|
Yield
|
6.82%
|
6.9%
|
6.82%
|
Capitalization / Revenue
|
0.83
x
|
0.78
x
|
0.67
x
|
EV / Revenue
|
1.76
x
|
1.64
x
|
1.4
x
|
EV / EBITDA
|
11.6
x
|
10.7
x
|
10.1
x
|
EV / FCF
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
Price to Book
|
1.04
x
|
1.11
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
131,647
|
-
|
-
|
Reference price
2 |
14.66
|
14.66
|
14.66
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,867
|
2,032
|
2,154
|
2,514
|
EBITDA
1 |
-
|
-
|
308.2
|
330.2
|
349.9
|
EBIT
1 |
-
|
70.92
|
130
|
146.4
|
160.6
|
Operating Margin
|
-
|
3.8%
|
6.4%
|
6.8%
|
6.39%
|
Earnings before Tax (EBT)
1 |
-
|
-76.22
|
-0.257
|
34.2
|
57.03
|
Net income
1 |
-81.3
|
-71.47
|
-4.891
|
17.52
|
45.4
|
Net margin
|
-
|
-3.83%
|
-0.24%
|
0.81%
|
1.81%
|
EPS
2 |
-1.240
|
-1.080
|
-0.0300
|
0.0950
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
1.000
|
1.012
|
1.000
|
Announcement Date
|
17/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
482.6
|
499.5
|
506
|
511.4
|
518.3
|
526.2
|
EBITDA
1 |
-
|
74.24
|
74.02
|
75.79
|
80.09
|
82.03
|
EBIT
1 |
25.66
|
24.8
|
28.8
|
32.1
|
35.25
|
37.46
|
Operating Margin
|
5.32%
|
4.96%
|
5.69%
|
6.28%
|
6.8%
|
7.12%
|
Earnings before Tax (EBT)
1 |
-31.07
|
-2.726
|
2.104
|
5.042
|
2.522
|
6.909
|
Net income
1 |
-27.42
|
-3.892
|
-1.534
|
-0.7123
|
3.039
|
5.257
|
Net margin
|
-5.68%
|
-0.78%
|
-0.3%
|
-0.14%
|
0.59%
|
1%
|
EPS
2 |
-0.4100
|
-0.0400
|
-0.0150
|
-
|
0.0150
|
0.0300
|
Dividend per Share
2 |
-
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
Announcement Date
|
21/03/24
|
13/05/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
1,886
|
1,842
|
1,837
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
6.121
x
|
5.579
x
|
5.25
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
0.18%
|
1.36%
|
2.65%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
14.10
|
13.20
|
12.50
|
Cash Flow per Share
2 |
-
|
-
|
1.260
|
1.390
|
-
|
Capex
1 |
-
|
-
|
32
|
32.2
|
33.4
|
Capex / Sales
|
-
|
-
|
1.57%
|
1.5%
|
1.33%
|
Announcement Date
|
17/03/23
|
21/03/24
|
-
|
-
|
-
|
Last Close Price
14.66
USD Average target price
15.88
USD Spread / Average Target +8.29% Consensus |
1st Jan change
|
Capi.
|
---|
| +14.97% | 61.99B | | +0.84% | 20.31B | | +0.51% | 14.01B | | +5.45% | 7.99B | | -5.80% | 6.14B | | +14.32% | 3.63B | | +2.24% | 3.38B | | +9.16% | 3.22B | | -6.13% | 3.08B |
Healthcare REITs
|